Literature DB >> 22778495

Mast cells and histamine: do they influence placental vascular network and development in preeclampsia?

Grzegorz Szewczyk1, Michał Pyzlak, Jakub Klimkiewicz, Wacław Smiertka, Magdalena Miedzińska-Maciejewska, Dariusz Szukiewicz.   

Abstract

UNLABELLED: The physiological course of pregnancy is closely related to adequate development of the placenta. Shallow invasion of trophoblast as well as decreased development of the placental vascular network are both common features of preeclampsia. To better understand the proangiogenic features of mast cells, in this study we aim to identify the potential relationship between the distribution of mast cells within the placenta and vascular network development.
MATERIAL AND METHODS: Placentas from preeclampsia-complicated pregnancies (n = 11) and from physiological pregnancies (n = 11) were acquired after cesarean section. The concentration of histamine was measured, and immunohistochemical staining for mast cell tryptase was performed. Morphometric analysis was then performed.
RESULTS: We noticed significant differences between the examined groups. Notably, in the preeclampsia group compared to the control group, we observed a higher mean histamine concentration, higher mast cell density (MCD), lower mean mast cell (MMCA) and lower vascular/extravascular (V/EVT) index. In physiological pregnancies, a positive correlation was observed between the histamine concentration and V/VEVT index as well as MCD and the V/VEVT index. In contrast, a negative correlation was observed between MMCA and the V/EVT index in physiological pregnancies.
CONCLUSIONS: Based on the data from our study, we suggest that a differential distribution of mast cells and corresponding changes in the concentration of histamine are involved in the defective placental vascularization seen in preeclamptic placentas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22778495      PMCID: PMC3388381          DOI: 10.1155/2012/307189

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


1. Introduction

Angiogenesis is a crucial process for the growth and development of new tissues. We can observe angiogenesis in neoplasms, during tissue repair after injury and in the placenta. Proper placental angiogenesis is necessary for the normal course of pregnancy and labor [1]. The pathogenesis of preeclampsia is still unclear, but it is known that shallow spiral artery invasion may contribute to preeclampsia development. Shallow spiral artery invasion results in poor placental perfusion and may lead to hypoxic stress in the fetus. Immaturity of extravillous trophoblastic cells has been identified as a cause of diminished spiral artery invasion [2]. The placental vascular network is defectively developed as well. In some preeclampsia-complicated pregnancies, the placenta and associated placental vascular network are diminished. Mast cells are found in the placenta in every stage of placenta development. Their potential role, apart from immunological properties, can be associated with proangiogenic activity. Mast-cell-derived mediators of known angiogenetic potential include vascular endothelial growth factor (VEGF), transforming growth factor beta (TGF-β), histamine, tumor necrosis factor alpha (TNF-α), interleukin-8, and basic fibroblast growth factor [3]. The activation and degranulation of mast cells in the place of angiogenesis stimulate vessel sprouting and sustain mast cell attraction and activation [4]. Data from the literature and our own experience suggest that mast cells may be involved in the pathogenesis of preeclampsia-complicated pregnancies [5, 6]. In this study, we examined the relationship between mast cells (number and morphological features), histamine concentration, and microvascular density in placentas obtained after delivery from normal and preeclampsia-complicated pregnancies.

2. Material and Methods

The characteristics of the patients are detailed in Table 1. Placental samples were obtained in a standardized manner after the dissection of fetal membranes. Three samples were excised from the maternal side of the placenta and two were excised from the fetal side. Macroscopically changed areas, large vessels, and fibrous tissues were avoided. Samples were taken immediately after cesarean sections in each group: preeclamptic women (PE, n = 11) and healthy women (control group, n = 11). In the PE group, cesarean sections were performed due to severe preeclampsia. In the control group, cesareans were performed due to severe myopia and breech presentation of the fetus. None of the patients included in the study had contractile activity [7]. The study was reviewed and accepted by the local ethic committee.
Table 1

The characteristics of patients included into the study.

PE group n = 11Control group n = 11
MedianRangeMedianRange
Mother's age3027–423023–37
Weeks of gestation37,535–403937–40
Birth weight (g)24851650–365034002630–3810
1st minute Apgar's score9,53–10109-10

3. Immunocytochemical Stainings

The tissue fragments were fixed in formaldehyde solution, dehydrogenized with 96% alcohol, acetone, and xylene and then paraffinized. Next, they were cut in microscopic slides and deparaffinized, and the intrinsic peroxidase activity was blocked with hydrogenium superoxide. The samples were then washed with PBS and incubated with normal human serum for 20 minutes. Excess antibody was removed, and the slides were incubated with mouse anti-tryptase antibody (Novocastra, 1 : 3000), followed by secondary anti-mouse biotinylated antibody and Novostain Super ABC Reagent (Novocastra). Both incubations lasted for 30 minutes. The slides were washed with PBS and exposed to 3,3′-diaminobenzidine (Immunotech) for 3 minutes as an electron donor and hydrogen peroxide as a substrate, resulting in a brown reaction product. The cells were then counterstained with Mayer's hematoxylin (Sigma) for 1 minute. Finally, the slides were mounted with DPX (Sigma). As a negative control, the slides were incubated with PBS instead of the primary antibody.

4. Histamine Concentration Assay

A fluorimetric method was applied as previously described [8]. The determination of histamine was based on a precolumn derivatization with o-phthaldialdehyde using reversed-phase high-performance liquid chromatography in perchloric acid extracts. A fluorescence detection system was used, with the excitation set at 360 nm and the emission read at 455 nm. The intra- and inter-assay coefficients of variation were 8.5% and 10.0%.

5. Morphometric Analysis

Morphometric analysis was carried out with the computer image analysis system Leica Quantimet 500C+ (Leica Cambridge Ltd. Cambridge, UK). The system consisted of an IBM Pentium computer operating at 120 MHz equipped with an ARK Logic 2000MT graphic card and graphic processor. The computer was connected to a CCD video camera JVC TK-1280E and Leica DMLB light microscope. Sections of placentas were imaged using a 20 : 1 objective and a 10 : 1,20 ocular. The optical image was focused by a video camera, and an analogue video signal was generated. An analogue to digital converter (ADC) produced a digitized video with distinct color level values in HSI system. The images were processed, and mast cells and placental vessels were clearly identified [9] (Figure 1).
Figure 1

Process of mast cells identification with morphometric software. Stage 1: initial picture obtained from microscope and saved in HSI colour system. Stage 2: binary image after detection of mast cells in distinct hue values. Stage 3: final reduction of noises and smoothing of detected fields.

Two independent researchers were responsible for image acquisition and analysis. All measurements were recorded in a blinded fashion. Neither researcher had previous knowledge of the clinical data. For each case, 50 random visual fields were analyzed. After system calibration, the area of a single analyzed image (visual field) was defined as approximately 0,14 mm2. The following parameters were analyzed: mast cell density (MCD), defined as number of mast cells per mm2 of placental tissue; mean mast cell area (MMCA), the mean area of mast cells cross-sections; shape of mast cells, defined as the ratio of long to short axis of a cell (with perfectly round cells defined as having 1.00 index); vascular/extravascular tissue index (V/EVT index), the ratio of vessel cross-section area to remaining placental tissue. Technical error caused by uniaxial sections of vessels was eliminated by accepting the lowest value of Ferret's diameter as the diameter for a single lumen. Vessels between 10 and 70 μm in diameter were included for analysis.

6. Statistical Analysis

Statistical analysis was performed with Statistica 8.0 (StatSoft, Poland). Groups were compared with Student's t-test. In each group analysis, correlation was measured between the histamine concentration, V/EVT index, and morphometric parameters of the mast cells. Differences were deemed statistically significant if P < 0, 05.

7. Results

Specific differences were observed in several examined parameters between the PE and control groups. The mean histamine concentration (ng of histamine per 1 g of tissue) was significantly higher in the PE group compared to the control group (245,6 ± SD 19,8 versus 175,1 ± SD 15,1; P = 0, 002). MCD (in cells/mm2) was also significantly higher in the PE group compared to the control group (7,67 ± SD 3,56 versus 2,89 ± SD 1,34; P = 0, 004). In contrast, the MMCA was significantly lower in the PE group in comparison to the control group (62,25 μm2 ± SD 18,91 versus 101,98 μm2  ± SD 57,91; P = 0, 0428). We also observed some differences in cell shape. Mast cells in the control group were longer than mast cells in the PE group (shape index 1,88 ± SD 0,8 versus 1,52 ± SD 0,39; P = 0, 051; refer to Table 2).
Table 2

Morphometric parameters analyzed in the study compared with Student's t-test. V/EVT index: vascular/extravascular tissue index, MCD: mast cell density, and MMCA: mean mast cell area. The statistically significant results are in bold.

PE groupControl group
meanSDmeanSD P
V/EVT index 0,15 ±0,04 0,23 ±0,074 0,005
MCD (n/mm2) 7,67 ±3,56 2,89 ±1,34 0,0004
MMCA (μm2) 62,25 ±18,91 101,98 ±57,91 0,0428
Shape index1,52±0,391,88±0,80,051
Morphometric assessment of placental circulature was performed and revealed a decrease in the V/EVT index in the PE group compared to the control group (0,15 ± SD 0,04 versus 0,23 ± SD 0,074; P = 0, 005; refer to Table 2). The analysis revealed a positive correlation between the histamine concentration and the V/VEVT index as well as between MCD and the V/VEVT index. A negative correlation existed between the MMCA and V/EVT index in the control group, while the PE group showed no significant correlation between these parameters. Specific values of correlation for these parameters are provided in Table 3.
Table 3

The indexes of correlation between histamine concentration and morphometric parameters of mast cells and V/EVT index in each group. V/EVT index: vascular/extravascular tissue index, MCD: mast cell density, MMCA: mean mast cell area. The statistically significant results are in bold.

PE group n = 11Control group n = 11
V/EVT indexV/EVT index
Histamine concentration (ng/1 g of tissue)0,48 0,74
MCD (n/mm2)0,03 0,82
MMCA (μm2)0,22 0,67
Shape index0,510,42

8. Discussion

Angiogenesis is the process of vessel growth from preexisting vessels, a process that requires stimulation by proangiogenic factors. Important stimulants of placental angiogenesis include VEGFs and placental growth factor, which act through the VEGF receptor family. VEGF production is stimulated by histamine acting through the H2 receptor [10]. Mast cells are pointed to as a potential source of potent proangiogenic factors during angiogenesis, including histamine, VEGF, bFGF, TGF-beta, TNF-alpha, and IL-8. Additionally, mast cells are a source of extracellular matrix-degrading proteinases [4]. In vitro models of angiogenesis observed in hypoxic conditions provide us with information on increased angiogenesis, which occurs mainly through increases in VEGF synthesis [11]. Histamine proangiogenetic action is provided through H1- and H2-receptor-mediated VEGF synthesis. Mast cell degranulation leads to a local increase in histamine concentration and therefore an increase in VEGF synthesis. Mast cells, however, synthesize and secrete VEGF apart from histamine. The final effect is vigorous formation of new vessels in place of mast cell degranulation [12, 13]. Decreases in mast cell density in connection with decreased histamine concentration correlated with lower V/EVT index values; nevertheless, this correlation was observed only in the control group. Decreased mast cell area may indicate changes in mast cell activation, perhaps as an effect of degranulation. Hypoxia, which is dominant during placenta formation, is a potent stimulator for mast cell activation and new vessel formation. The most important pathway through which hypoxia stimulates angiogenesis is the activation of hypoxia inducible factor-1α (HIF-1α) transcription and further synthesis of VEGF. It is also observed that the synthesis of histamine within mast cells and their degranulation is increased after stimulation with HIF-1α that is achieved through histidine decarboxylase (HDC, EC:4.1.1.22) [14]. Preeclampsia is a specific state of pregnancy associated with hypertension and proteinuria. Shallow trophoblast invasion of maternal spiral arteries results in an increase in systemic blood pressure. The leading hypothesis for preeclampsia pathogenesis suggests it may arise in order to maintain placental perfusion pressure at a satisfactory level [15]. The vascular bed of the placenta is diminished as a whole, with reduced branching and malformations observed; blood vessels are characterized by decreased number, lumen diameter, and total lumen area [16]. Data from our study support this previous finding, as the V/EVT index was decreased in the PE group compared to the control group. The reduced proportion of vascular area may reflect diminished placental angiogenesis in the first trimester of pregnancy. The decreased vascular network development is a result of a multifactorial pathogenetic course as well as inherited conditions. The differences in mast cell organization observed between the PE and control groups suggest that mast cells take part in the process of vessel development. Because mast cells are observed to gather close to blood vessels just before the process of angiogenesis begins (this is particularly characteristic for neoplasm growth [17]), we expect an expanded vascular network in preeclamptic placentas. In our study, we observed an increase in mast cell density and an increase in histamine concentration but a low V/EVT ratio. We conclude that in PE, susceptibility to histamine and/or other mast cell proangiogenic compounds may be decreased. In PE placentas, the mast cells had a different shape and smaller area in comparison to the control group. The data suggest that we observed mast cells after an intensive degranulation, as we also found an increased concentration of histamine [18]. Increased mast cell density and histamine concentration can be a compensation effect for incorrect vascular network development. On the other hand, we cannot exclude impairments in histamine receptor configuration. Functional predominance of intracellular histamine receptor (HIC) over H1 and H2 receptors may be a causative factor in the observed decreased angiogenesis [19]. The reason for the decreased V/EVT index in preeclamptic placentas may be associated not only with decreased angiogenesis but also with fibroblast proliferation and fibrosis in the extravascular area. In the examined material, the V/EVT index was assessed in placentas obtained during the third trimester. A remodeling of extravascular tissue during the pregnancy should also be taken into consideration. Mast cells are sources of matrix-degrading enzymes including collagenases and gelatinases [4]. Prolonged stimulation of mast cells with hypoxia leads to an increase in collagenolytic activity and an accumulation of low molecular collagen fragments, thus providing a stimulatory factor to fibroblasts and smooth muscle cell proliferation [20]. A dominance of activated fibroblasts may lead to a decrease in the V/EVT index. We conclude that mast cells are strongly involved in the pathogenesis of preeclampsia, as their concentration and activity are changed in preeclamptic placentas in comparison to physiological placentas. Low vascularization in preeclamptic placentas despite higher histamine concentration and accumulation of mast cells suggests that mast cells fail in their proangiogenic potential, concurrently increasing extravascular activity.
  18 in total

1.  Activation and inhibition of mast cells degranulation affect their morphometric parameters.

Authors:  F Levi-Schaffer; D Slovik; L Armetti; D Pickholtz; E Touitou
Journal:  Life Sci       Date:  2000-04-14       Impact factor: 5.037

2.  A modified fluorometric procedure for tissue histamine and its distribution in various animals.

Authors:  A H Anton; D F Sayre
Journal:  J Pharmacol Exp Ther       Date:  1969-04       Impact factor: 4.030

Review 3.  Lung mast cells and hypoxic pulmonary hypertension.

Authors:  H Maxová; J Herget; M Vízek
Journal:  Physiol Res       Date:  2011-12-20       Impact factor: 1.881

4.  Enhancement by histamine of vascular endothelial growth factor production in granulation tissue via H(2) receptors.

Authors:  A K Ghosh; N Hirasawa; K Ohuchi
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

5.  A novel source of mast cells: the human placenta.

Authors:  W M Purcell; T H Hanahoe
Journal:  Agents Actions       Date:  1991-05

6.  Quantitative analysis of trophoblast invasion in preeclampsia.

Authors:  Thajasvarie Naicker; Shaun M Khedun; Jagidesa Moodley; Robert Pijnenborg
Journal:  Acta Obstet Gynecol Scand       Date:  2003-08       Impact factor: 3.636

Review 7.  Mast cells and angiogenesis.

Authors:  Klas Norrby
Journal:  APMIS       Date:  2002-05       Impact factor: 3.205

8.  Mast-cell histamine is angiogenic through receptors for histamine1 and histamine2.

Authors:  J Sörbo; A Jakobsson; K Norrby
Journal:  Int J Exp Pathol       Date:  1994-02       Impact factor: 1.925

9.  A morphometric method to evaluate angiogenesis kinetics in the rat mesentery.

Authors:  A E Jakobsson; K Norrby; L E Ericson
Journal:  Int J Exp Pathol       Date:  1994-06       Impact factor: 1.925

10.  Mast cells and matrix degradation at sites of tumour invasion in rat mammary adenocarcinoma.

Authors:  M K Dabbous; R Walker; L Haney; L M Carter; G L Nicolson; D E Woolley
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

View more
  13 in total

1.  Genetic recapitulation of human pre-eclampsia risk during convergent evolution of reduced placental invasiveness in eutherian mammals.

Authors:  Michael G Elliot; Bernard J Crespi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-03-05       Impact factor: 6.237

Review 2.  Mast Cell Activation Syndrome in COVID-19 and Female Reproductive Function: Theoretical Background vs. Accumulating Clinical Evidence.

Authors:  Dariusz Szukiewicz; Piotr Wojdasiewicz; Mateusz Watroba; Grzegorz Szewczyk
Journal:  J Immunol Res       Date:  2022-06-22       Impact factor: 4.493

3.  Network-Based Analysis Reveals Novel Biomarkers in Peripheral Blood of Patients With Preeclampsia.

Authors:  Jing Lin; Yu Meng; Meng-Fan Song; Wei Gu
Journal:  Front Mol Biosci       Date:  2022-06-16

Review 4.  Cellular immune responses in the pathophysiology of preeclampsia.

Authors:  Derek Miller; Kenichiro Motomura; Jose Galaz; Meyer Gershater; Eun D Lee; Roberto Romero; Nardhy Gomez-Lopez
Journal:  J Leukoc Biol       Date:  2021-04-13       Impact factor: 6.011

5.  Transfer of regulatory T cells into abortion-prone mice promotes the expansion of uterine mast cells and normalizes early pregnancy angiogenesis.

Authors:  Katja Woidacki; Nicole Meyer; Anne Schumacher; Alexandra Goldschmidt; Marcus Maurer; Ana Claudia Zenclussen
Journal:  Sci Rep       Date:  2015-09-10       Impact factor: 4.379

6.  The Placental Innate Immune System Is Altered in Early-Onset Preeclampsia, but Not in Late-Onset Preeclampsia.

Authors:  Michelle Broekhuizen; Emilie Hitzerd; Thierry P P van den Bosch; Jasper Dumas; Robert M Verdijk; Bas B van Rijn; A H Jan Danser; Casper H J van Eijck; Irwin K M Reiss; Dana A M Mustafa
Journal:  Front Immunol       Date:  2021-12-21       Impact factor: 7.561

7.  Insights into Early-Pregnancy Mechanisms: Mast Cells and Chymase CMA1 Shape the Phenotype and Modulate the Functionality of Human Trophoblast Cells, Vascular Smooth-Muscle Cells and Endothelial Cells.

Authors:  Ningjuan Zhang; Anne Schumacher; Beate Fink; Mario Bauer; Ana Claudia Zenclussen; Nicole Meyer
Journal:  Cells       Date:  2022-03-29       Impact factor: 6.600

8.  Significance of mast cell distribution in placental tissue and membranes in spontaneous preterm birth.

Authors:  Kate Needham; Mitali Fadia; Jane E Dahlstrom; Kirsti Harrington; Bruce Shadbolt; Stephen J Robson
Journal:  J Inflamm Res       Date:  2016-07-08

Review 9.  Immune Cells in the Uterine Remodeling: Are They the Target of Endocrine Disrupting Chemicals?

Authors:  Nicole Meyer; Ana Claudia Zenclussen
Journal:  Front Immunol       Date:  2020-02-19       Impact factor: 7.561

Review 10.  Mechanisms of Key Innate Immune Cells in Early- and Late-Onset Preeclampsia.

Authors:  Ingrid Aneman; Dillan Pienaar; Sonja Suvakov; Tatjana P Simic; Vesna D Garovic; Lana McClements
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.